register free | resend password

Surgery & Treatments

Themenbereich / / Surgery & Treatments

Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Brussels, May 23: Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe''s best brains to pave the way for future

Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects have joined forces. epiXchange 2018 is a unique global community building event, designed to gather a critical mass of epilepsy researchers to exchange about latest progress in research aiming to improve the way epilepsy is diagnosed and treated and thereby increase the quality of life of affected people. Six of these projects were funded through the 7th Framework Pr ...


IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call

RICHLAND, WA -- (Marketwired) -- 11/08/17 -- IsoRay, Inc. (the "Company") (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced that it will host a teleconference to discuss first quarter fiscal 2018 financial results on Tuesday, November 14, 2017, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the first quarter of fiscal 2018 ended September 30, 2017, immedi ...


The New Merivaara Q-Flow surgical light can reduce the risk of hospital infections

The new Merivaara Q-Flow is a major step forward from traditional operating room lights. Designed and manufactured in Finland, Q-Flow was developed to fulfil the needs of the modern surgical team. It offers improvements on many standard features in the industry as well as radical innovations. “I believe this is one of the best operating theatre lights in the world,” says CEO Markku Aherto. “We are very excited about this excellent product.” The light achieves superb colour rendering, particularly in red and skin shades, which makes the product perfect for a variety of surgical procedures suc ...


Morristown Cosmetic Dentists Launch New Responsive Website with Unique Design

MORRISTOWN, NJ -- (Marketwired) -- 06/29/17 -- The renowned general, restorative, and at Aesthetic Smiles of New Jersey recently collaborated with the team at Rosemont Media -- a San Diego-based digital marketing firm -- to provide patients with an all-encompassing informational resource detailing the range of oral health services offered at their Morristown practice. Together, they modernized Aesthetic Smiles'' online presence with a sleek website design that showcases custom-built features, allows for easy navigation, and enhances the overall patient experience.Aesthetic Smiles o ...


Cannabis Science Invests in the Research and Development of Cannabinoid-based Medications to Treat COPD and Asthma

IRVINE, CA -- (Marketwired) -- 06/23/17 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has invested in the research and development of new cannabinoid-based medications to treat Chronic Obstructive Pulmonary Disease (COPD) and Asthma. According to the Centers for Disease Control and Prevention, in the U.S. alone over 15 million people have been diagnosed with COPD, and over 25 million with Asthma."More institutions continue to realize that Cannabis-derived medications are indeed a p ...


Eloxx Pharmacueticals Receives A US$5 Million Investment from Quark Venture and GF Securities to Advance A Novel Disease-Modifying Therapy Targeting Genetic Diseases

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/08/17 -- Today, Quark Venture Inc. and GF Securities announced a $US5 million investment Eloxx Pharmaceuticals through their Global Health Science Fund. This investment is part of a US$24 million financing Series C round led by Pontifax, a leading VC in the Life Sciences arena and co-founder of Eloxx Pharmaceuticals. Headquartered in Rehovot, Israel, Eloxx Pharmaceuticals is a clinical stage company developing first in class therapeutics to treat genetic diseases caused by non-sense mutations."This investment expands our global portfoli ...


Las Vegas Cataract Surgeon Says the TECNIS Symfony Intraocular Lens Offers Patients an Excellent New Lifestyle Option

LAS VEGAS, NV -- (Marketwired) -- 05/03/17 -- Helga F. Pizio, MD, FACS, cataract surgeon and founder of , has been practicing for more than 20 years in Las Vegas. Dr. Pizio has been involved with many new developments in the field of vision care, particularly when it comes to cataract surgery and intraocular lens implants (IOLs). With the introduction of the latest FDA-approved , Dr. Pizio believes the next generation of lens technology for cataract surgery patients desiring to gain a more complete range of vision from distance to near without the need for glasses or contacts is here now.are ...


EastGate Biotech''s Recent Acquisition OMNI Surgery + Anti-Aging Centre Appoints Dr. Ishaan Sundar as Medical Director

WEST CALDWELL, NJ and TORONTO, ON -- (Marketwired) -- 04/12/17 -- EastGate Biotech Corp. (OTC PINK: ETBI) (), an emerging pharmaceutical company that produces and distributes innovative and healthy nutraceuticals based on natural therapies as well as focusing on new pharmaceutical developments has announced that its recent acquisition, OMNI Surgery and Anti-Aging Centre has appointed a new Medical Director. Dr. Ishaan Sundar has assumed the role of Medical Director effective immediately. Educated by the American Academy of Aesthetic Medicine, American Cosmetic Cellular Medicine Association, L ...


Quark Venture announces US$4.5 million in funding to support critical work in cancer immunotherapy of two world-leading scientists at Harvard Medical School (HMS)

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/06/17 -- Today, Quark Venture Inc. announced a signing of a unique research sponsorship agreement with Harvard University''s Office of Technology Development (OTD). The US$4.5 million supports the joint research of principal investigators Arlene Sharpe, MD, PhD, and Dennis Kasper, MD, trailblazers in their fields of cancer immunology and microbiome science, respectively.The premise of the research is that the missing ingredients for cancer immunotherapy may be found in the gut. Combining cutting-edge insights from gut microbiology, ...


UA Multimedia Initiates Process to Change the Company Name and Ticker Symbol

IRVINE, CA -- (Marketwired) -- 02/13/17 -- UA Multimedia, Inc. (OTC: UAMM), a technology and indoor growing solution provider, is pleased to announce that the Company has initiated the process to change its company name and ticker symbol.As a next step beyond achieving the Current status with OTC Markets, the Company has received board approval to change its company name and trading symbol to better reflect its new business direction and to facilitate successful branding efforts. The Company expects to complete the process within thirty days.The development of the personal indoor grow station ...


Brown Technical Media Corp. Completes Acquisition of One Exam Prep

HOUSTON, TX -- (Marketwired) -- 01/27/17 -- Brown Technical Media Corp., a division of Panther Biotechnology, Inc. (OTCQB: PBYA) is pleased to announce today that it has closed the acquisition of One Exam Prep, LLC (OEP), , a Florida limited liability company, pursuant to the executed binding letter of intent announced on December 15, 2016. OEP is in the business of exam preparation with a focus on construction training and certification.OEP is based in Coconut Creek, Florida and offers eLearning courses and weekly training classes and certification in a wide variety of topics for contractors ...


Quark Venture and GF Securities Invest Through the Global Health Sciences Fund in Biscayne Neurotherapeutics to Advance A Novel Anti-Epileptic Agent

VANCOUVER, BRITISH COLUMBIA and MIAMI, FLORIDA -- (Marketwired) -- 01/27/17 -- Today, Quark Venture Inc., and GF Securities announced a US$1.6 million investment in Biscayne Neurotherapeutics (Biscayne), through the Global Health Sciences Fund. Biscayne''s lead compound BIS-001, is in clinical development as a novel anti-epileptic agent. Quark Venture and GF Securities were joined by Mesa Verde Venture Partners of San Diego and current Biscayne shareholders for a total Series B raise of over US$3 million.The Series B investment will enable Biscayne to initiate and complete a Phase ...


Brown Technical Media Corp. Announces Record Sales for 2016

HOUSTON, TX -- (Marketwired) -- 01/13/17 -- Brown Technical Media Corp., a division of Panther Biotechnology Inc. (OTC PINK: PBYA), is pleased to announce today that it has achieved record sales for the calendar year 2016 for its line of products in e-learning and training, exam preparation, continuing education and compliance materials for career advancement for a wide variety of technical fields. Brown is building the first full service training and career advancement brand for the skilled trades.Orders for 2016 surpassed the goal of 20,000 compared to only 7,528 in 2015 representing over a ...


Fogarty Institute for Innovation Names Andrew Cleeland as CEO

MOUNTAIN VIEW, CA -- (Marketwired) -- 01/09/17 -- The Fogarty Institute for Innovation today announced that its board of directors has named Andrew Cleeland as chief executive officer, effective immediately.Cleeland currently holds the position of vice president and general manager of Medtronic''s Transcatheter Mitral Valve Replacement (TMVR) Venture, formerly Twelve Inc., where he was president and CEO. He succeeds Ann Fyfe, who led the Institute for five years."Andrew is a proven leader who will advance the Institute''s mission to promote medical innovation," s ...


Cannabis Science Inc. (CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce Joint Research and Drug Development Agreement; Collaborative Research Agreement

BOSTON, MA -- (Marketwired) -- 01/06/17 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medications, is proud to announce a collaborative research agreement with Dana Farber/Harvard Cancer Center (DF/HCC). The agreement lays the foundation for a cooperative research initiative to explore and develop new cannabinoid medicines to fight cancer. This agreement is also the first step in the development of clinical trials that will lead to approval of successful cannabinoids by the FDA."We believe that collaborative cutting-edge w ...


Quark Venture and GF Securities Invest US$25 Million in Microbion to Advance a New Class of Drugs That Combat Antibiotic-Resistant Infections

VANCOUVER, BRITISH COLUMBIA and BOZEMAN, MONTANA -- (Marketwired) -- 01/05/17 -- Today, Quark Venture Inc., a Vancouver-based health sciences venture capital company and GF Securities, a leading investment bank in Hong Kong, announced a US$25 million investment in Microbion Corporation through its Global Health Sciences Venture Fund. Microbion, co-located in Vancouver, BC and Bozeman, MT, is a clinical stage biopharmaceutical company specializing in the treatment of hard to treat and antibiotic-resistant infections. Microbion''s lead compound, MBN-101, is the first in a new class o ...


Brown Technical Media Corp. Moves into $35 Billion Virtual Reality Market via HVAC Training

HOUSTON, TX -- (Marketwired) -- 01/05/17 -- Brown Technical Media Corp., a division of Panther Biotechnology (OTC PINK: PBYA), is pleased to announce today that it has executed an exclusive distribution and publishing agreement with The Training Center of Air Conditioning and Heating, (). This transaction further expands Brown''s strategy to utilize virtual reality in the eLearning segment of its business.Brown is disrupting the technical vocations training and certification industry by creating the first full service training and career advancement brand in the technical fields and ...


Panther Biotechnology, Inc. Announces Record Date for Biotechnology Milestone Earn-Out Consideration Shares in Response to Recent Positive Feedback from the FDA

HOUSTON, TX -- (Marketwired) -- 12/16/16 -- Panther Biotechnology, Inc. (OTC PINK: PBYA) or Panther, has announced today that it has set a Record Date or Earn-Out Record Date for shareholders of record to participate in the Earn-Out Consideration afforded to the Earn-Out Shareholders pursuant to the Share Exchange Agreement between Panther Biotechnology, Inc. and Brown Technical Media Corp. filed on November 15th, 2016. The record date for Panther shareholders who are eligible to receive the Earn-Out Consideration is set for January 31st, 2017. Panther expects to file its Form 10K for fiscal ...


Brown Technical Media Corp., a Division of Panther Biotechnology Inc., Signs a Binding Letter of Intent to Acquire One Exam Prep

HOUSTON, TX -- (Marketwired) -- 12/15/16 -- Brown Technical Media Corp., () (Brown), a division of Panther Biotechnology, Inc. (OTC PINK: PBYA) (Panther), is pleased to announce today that it has executed a binding letter of intent to acquire One Exam Prep, LLC () (OEP), a Florida limited liability company, which is in the business of exam preparation with a focus on construction training and certification. OEP will be managed as a new division of Panther.Based in Coconut Creek, Florida, OEP offers weekly training classes and certification courses in a wide variety of topics for contractors w ...


Quark Venture Invests $4 Million in A New Technology That Harnesses the Body''s Natural Immune System to Combat Disease

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/01/16 -- Today, Quark Venture Inc., a Vancouver-based venture capital company, announced a $4 million investment in SQZ Biotech, a company originating out of Dr. Klavs Jensen and Robert Langer''s famed laboratories at the Massachusetts Institute of Technology (MIT) in Boston. Quark Venture joins GV (formerly Google Ventures), NanoDimension, Polaris Partners and others, bringing the total financing round to $24 million.SQZ Biotech is developing a new generation of cell therapies that harness the body''s natural immune syst ...


Page 1 from 26:  1 2  3  4  5  .. » 26

All members: 8 810
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 60

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.


[ more PressReleases ][ RSS-Feed ]